Showing results (41-50 of 220) with videos related to
Sort By:
Pageof 22
Medrxiv : the Preprint Server for Health Sciences|February 3, 2021
The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination seraSonia Jangra, Chengjin Ye, Raveen Rathnasinghe, et al.Frontiers in Immunology|October 4, 2021
Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in MiceYonghong Liu, Shirin Strohmeier, Irene González-Domínguez, et al.Cell Host & Microbe|October 22, 2013
HIV-1 Vif adaptation to human APOBEC3H haplotypesMarcel Ooms, Bonnie Brayton, Michael Letko, et al.Journal of Virology|September 16, 2004
Dynamics of intermittent viremia during highly active antiretroviral therapy in patients who initiate therapy during chronic versus acute and early human immunodeficiency virus type 1 infectionMichele Di Mascio, Martin Markowitz, Michael Louie, et al.Msphere|February 11, 2021
Identification and Characterization of Novel Antibody Epitopes on the N2 NeuraminidaseEricka Kirkpatrick Roubidoux, Meagan McMahon, Juan Manuel Carreño, et al.Journal of Virology|June 20, 2002
Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failureGustavo H Kijak, Viviana Simon, Peter Balfe, et al.Mbio|December 10, 2025
The pandemic gap of respiratory viruses during the COVID-19 pandemicViviana Simon, Daniel Floda, Charles Gleason, et al.Cell Reports|October 27, 2016
A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T CellsJudd F Hultquist, Kathrin Schumann, Jonathan M Woo, et al.Mbio|April 25, 2022
Structure of a Vaccine-Induced, Germline-Encoded Human Antibody Defines a Neutralizing Epitope on the SARS-CoV-2 Spike N-Terminal DomainClara G Altomare, Daniel C Adelsberg, Juan Manuel Carreno, et al.Cell Reports. Medicine|March 20, 2024
SARS-CoV-2 BA.1 and BA.2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ.1.1 or XBB.1.5Anass Abbad, Temima Yellin, Gagandeep Singh, et al.Pageof 22